<DOC>
	<DOCNO>NCT01192503</DOCNO>
	<brief_summary>The purpose study find rasagiline improves RLS symptom . We also want make sure rasagiline safe give people RLS .</brief_summary>
	<brief_title>Safety Efficacy Rasagiline Restless Legs Syndrome</brief_title>
	<detailed_description>The primary objective determine rasagiline , dosage 1mg/day , non-futile treatment RLS , measure International RLS Study Group Rating Scale ( IRLS ) . The primary outcome variable change IRLS baseline Week 12 . The secondary objective determine rasagiline , dosage 1mg/day , safe well-tolerated participant RLS . Also , determine rasagiline improve measure global clinical change , sleep quality , excessive sleepiness , quality life , depressive symptom .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<criteria>Men woman least 18 year age , capable providing inform consent Diagnosed idiopathic RLS , define meet International RLS Study Group diagnostic criterion without evidence secondary cause RLS Moderate severe symptom , define score 15 great International RLS Study Group Rating Scale ( IRLS ) Not currently receive treatment RLS . A 30day washout period require participant dopamine agonist therapy . Stable dos iron supplementation allow On stable dose follow antidepressant , least 30 day prior baseline visit : Amitriptyline , 50mg/day Trazodone , 100mg/day Citalopram , 20mg/day Escitalopram , 10mg/day Paroxetine , 30mg/day Sertraline , 100mg/day Female subject must childbearing potential must agree use contraception duration study Signs consistent secondary cause RLS : History initial unresponsiveness dopaminergic RLS treatment despite adequate dose initial therapy Use another MAO inhibitor within 30 day baseline visit Allergy adverse reaction rasagiline Prior adverse reaction tyraminecontaining food Use meperidine opiate within 30 day baseline visit Use benzodiazepine within 30 day baseline visit Use antidepressant , include TCAs , SSRIs , SNRIs , except permit list Use drug supplement contraindicate rasagiline , include St. John 's wort , mirtazapine , cyclobenzaprine , dextromethorphan , cold product contain ephedrine , pseudoephedrine Scheduled undergo elective surgery course study Active medical psychiatric illness require change treatment course study jeopardize subject 's ability remain study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Restless Legs Syndrome</keyword>
	<keyword>rasagiline</keyword>
	<keyword>futility</keyword>
</DOC>